2020
DOI: 10.3390/cells9030574
|View full text |Cite
|
Sign up to set email alerts
|

At the Crossroads of Apoptosis and Autophagy: Multiple Roles of the Co-Chaperone BAG3 in Stress and Therapy Resistance of Cancer

Abstract: BAG3, a multifunctional HSP70 co-chaperone and anti-apoptotic protein that interacts with the ATPase domain of HSP70 through its C-terminal BAG domain plays a key physiological role in cellular proteostasis. The HSP70/BAG3 complex determines the levels of a large number of selective client proteins by regulating their turnover via the two major protein degradation pathways, i.e. proteasomal degradation and macroautophagy. On the one hand, BAG3 competes with BAG1 for binding to HSP70, thereby preventing the pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
49
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 50 publications
(49 citation statements)
references
References 71 publications
0
49
0
Order By: Relevance
“…Increased BAG3 expression is shared across all cancer types and can create a desirable microenvironment for cancer progression in pancreatic ductal adenocarcinoma, melanomas, lung cancer, breast cancer, and prostate cancer [180]. Since there is a broad involvement for BAG3 in multiple different cancer types, research has focused on BAG3 inhibitors [181]. A BAG3 inhibitor showed promising efficacy in inhibiting cancer cell proliferation in breast cancer, prostate cancer, pancreatic cancer, and lung cancer cell lines [182].…”
Section: Cancermentioning
confidence: 99%
“…Increased BAG3 expression is shared across all cancer types and can create a desirable microenvironment for cancer progression in pancreatic ductal adenocarcinoma, melanomas, lung cancer, breast cancer, and prostate cancer [180]. Since there is a broad involvement for BAG3 in multiple different cancer types, research has focused on BAG3 inhibitors [181]. A BAG3 inhibitor showed promising efficacy in inhibiting cancer cell proliferation in breast cancer, prostate cancer, pancreatic cancer, and lung cancer cell lines [182].…”
Section: Cancermentioning
confidence: 99%
“…Increased BAG3 expression is shared across all cancer types and can create a desirable microenvironment for cancer progression in pancreatic ductal adenocarcinoma, melanomas, lung cancer, breast cancer, and prostate cancer [157]. Since there is a broad involvement for BAG3 in multiple different cancer types, research has focused on BAG3 inhibitors [158]. A BAG3 inhibitor showed promising efficacy in inhibiting cancer cell proliferation in breast cancer, prostate cancer, pancreatic cancer, and lung cancer cell lines [159].…”
Section: Cancermentioning
confidence: 99%
“…Also, BAG3 interacts with HSP70 and LC3 delivering polyubiquitinated proteins to the autophagy pathway. (179).…”
Section: Autophagy In Stress Responses Cancer Progression and Metasmentioning
confidence: 99%